IDH1 and central nervous system cancer: While a protective role is often expected due to its reduction in glioma individuals [16,17], a higher abundance of this phylum was paradoxically noted in patients with worse prognosis IDH–wild-type glioblastoma compared to IDH-mutant individuals [21].